Emalex Biosciences Appoints Dr. Atul R. Mahableshwarkar as Senior Vice President of Drug Development
CHICAGO, IL, August 6, 2019 — Emalex Biosciences Inc., a biopharmaceutical company developing innovative therapies for patients with neurological and psychiatric conditions, today announced the appointment of Atul Mahableshwarkar, MD, as Senior Vice President of Drug Development. In this capacity, Dr. Mahableshwarkar will provide leadership … Read more